Reporting guidelines can improve transparency and reporting quality. No guideline exists for reporting case series. Our objective was to develop reporting guidelines for surgical case series. 
Introduction
Case series often appear in the surgical and wider healthcare literature but also in social sciences and the humanities [3] . Dekkers et al. defined a case series as an uncontrolled study that either samples participants with both a specific intervention (exposure) and a specific outcome, or samples participants with a specific outcome of interest regardless of their exposure status [1] . A series sampled only on exposure is a cohort study. A report of a case series is commonly a retrospective review of a string of patients with a unifying feature -be that exposure (including treatment) or outcome, or both. There has also been significant confusion between case series and single group cohort studies [2] .
As with case reports, their value has been debated [3, 4] . In the age of evidence-based medicine (EBM), with the randomised controlled trial as the standard to show the efficacy of a particular treatment, what is their role? Level four evidence was still the most common study type in a bibliometric analysis of research published in 2013 in the specialties of plastic surgery, orthopaedic surgery, otolaryngology and neurosurgery, with significant outputs in maxillo-facial surgery (33%) and vascular surgery (15%) [5] . The use of a case series in the recognition of a new disease was exemplified in 1999 by the epidemic of West Nile encephalitis in New York [6] . Historically, case series were important in identifying the impact of maternal drinking and pregnancy outcome and the role of vitamin C in preventing scurvy [7, 8] . A single case series can lead to very significant change, from the widespread use of negative pressure dressings following a case series of 10 patients [9] to a 49 patient case series that led to a new classification system for haemangiomas and vascular malformations in 1982, still in use today [10] .
Albrecht et al. studied reports of case series and found that a high proportion led to follow-up trials and that they were useful in establishing an early evidence base for new treatments of rare diseases in which trials would not be feasible [11] . For some specialties, establishing control groups may be difficult, such as in accident and emergency medicine or paediatric medicine or surgery. In the social sciences, many social psychology studies have been case series, for example Yale psychologist Stanley Milgram's seminal work on obedience to authority figures [12] .
In a 2005 report, Dalziel et al. found that case series were used in 30% of Health Technology Assessments (HTA) used in the provision and suitability of care [13] . Poor reporting in the case series included in their study, however, severely constrained their analysis and investigation of the hypothesis that findings in case series may be affected by methodological characteristics [10] . Readers need complete, transparent information in all reports of research. Poor reporting of case series undermines critical appraisal, assessment of external validity and whether, for instance, surgeons should change their practice.
No standardised reporting criteria have been developed within a robust methodological framework for case series. The aim of the present study was to close this gap and produce a reporting guideline for case series that is methodologically robust, easy to use, and accepted internationally across a broad range of specialties and disciplines. Following guidance on guideline development, the early steps in this process require an analysis of previous literature to identify previous guidance (if any) and to analyse relevant evidence on the quality of reporting of published research articles within the domain of interest [14] . Our group recently completed a systematic review on the reporting quality of case series in surgery over the period 1990e2014 [15] . From 92 articles that met the inclusion criteria, methodological and reporting issues identified were: failure to use standardised definitions (57%), missing or selective data (66%), lack of transparency or incomplete reporting (70%), whether alternative study designs were considered (11%) and other issues (52%) such as failure to clearly define the patient population under investigation, selection bias, insufficient followup time, need for validated outcomes.
We recently developed the SCARE Guidelines for Case Reports using a DELPHI consensus exercise, which have now been adopted by several journals [16] . Following this experience, the objective of this research was to conduct a Delphi consensus exercise amongst experienced surgical case series reviewers and editors to develop the Preferred Reporting Of CasE Series in Surgery (PROCESS) Guideline.
Developing the PROCESS guideline
We issued a survey using Google Forms (https://www.google.co. uk/forms/about) asking participants in round one to help define surgical case series and what items should be included in them. In a subsequent round, participants were asked to rate their level of agreement with the guideline items from round one as well as items from the SCARE guidelines and any additional items that were suggested using a nine-point Likert scale as proposed by the GRADE group [17] . In this scale 1 to 3 signifies an outcome of limited importance, 4 to 6 important but not critical and 7 to 9 critical. If 70% or more of respondents scored an item 7 to 9 and fewer than 15% scored it 1 to 3, that item was incorporated in the reporting guideline. Similarly, consensus that an outcome should not be included was 70% or more scoring it 1 to 3 and 15% or less scoring it 7 to 9. The entire process was conducted electronically and there was no pre-determined number of Delphi rounds.
Participant selection
Surgeons and others with significant experience in reviewing or editing case reports were selected. They were drawn from the reviewer pool of IJS Case Reports (the top 150 were invited) as well as those who have written on the topic of case series and case reports in the past. In total 59 participants agreed to the invitation to participate in this study, representing 21 countries and all ten surgical specialties as well as allied specialties including; dermatology, pathology, oncology, clinical pharmacology, acute care surgery, with many participants also occupying positions on journal editorial boards [18].
Results
In round 1, there was a 49% (29/59) response rate. The participant responses are integrated into Table 1 .
Following adjustment of the guideline with incorporation of recommended changes, round 2 commenced (see Tables 2 and 3 ). There was an 81% (48/59) response rate. All guideline items were approved by the participants with Likert scores 7e9 awarded by >70% of respondents, apart from "4a -registration and ethics -state the research registry number in accordance with the declaration of Helsinki", which had scores of 7e9 from 65% of participants. However, as this item is part of the declaration of Helsinki, it cannot be removed or augmented. Table 3 constitutes the PROCESS guideline, and this is provided again in an Appendix, together with a column in which the author can state the page number on which the criterion was achieved. We recommend that all authors submitting case series should submit a completed PROCESS checklist with their manuscript and also state explicitly in their report that they have complied with the PROCESS guideline, which they should cite in their paper. The guideline represents the minimum of what should be reported and we encourage authors to provide additional details that are relevant. So, when should a case series be performed and when should these guidelines be used? For surgical case series specifically, the following can also be advocated: rare diseases or rare circumstances (such as emergencies), logistical difficulties or where ethical issues may arise with prospective randomised studies e.g. paediatric populations, new diseases e their description, natural history and management, studying the mechanism of disease and studying the impact of established procedures. In addition, late or delayed effects following surgical interventions, such as biliary malignancy after biliodigestive anastomosis, could be collated into a case series. Where a new technique or device has been conceived and requires development and assessment, the IDEAL (Idea, Development, Exploration, Assessment and Long-term follow-up) framework is recommended [19] .
PROCESS guideline

Endorsement
The PROCESS guideline has been endorsed by the IJS, IJS Case Reports, IJS Open, Annals of Medicine and Surgery, IJS Oncology, and IJS Short Reports.
Conclusion
After completion of two DELPHI rounds consensus was reached among a multidisciplinary and expert group in the area of surgery and case series. If used appropriately, the PROCESS guidelines will aid in raising the reporting quality of surgical case series. We encourage authors, reviewers, editors, journals, publishers and the wider surgical and scholarly community to adopt these. We look forward to feedback from the community as well as studies of its implementation to help inform a future revision of these guidelines.
PROCESS group participants
The following people contributed to the PROCESS Guideline: Raafat Afifi, Cairo University, Raha Alahmadi, King Faisal Specialist Hospital and Research Centre, Joerg Albrecht, John H. Stroger Jr. Hospital of Cook County, Abdulrahman Alsawadi, Colchester Hospital University NHS Foundation Trust, Jeffrey K. Aronson, Radcliffe From the first round results, a case series is being defined as: "an observational study of an uncontrolled group of patients collected or sampled on the basis of a specific disease/exposure/intervention or a specific outcome of interest."
96% (44/46)
A Case Series must be differentiated from a Cohort Study so we have defined those to following the first round results. "A Cohort Study is a comparative study typically involving two or more groups of patients that are sampled only on the basis of a specific exposure or intervention." This definition is similar to that put forward by the Centre of Evidence Based Medicine at Oxford University: http://www.cebm.net/ glossary/.
76% (35/46)
A single group cohort may still be utilised e.g. for prognostic studies. 
